HealthQuill Drugs
The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40% decline in maternal deaths as one maternal death occurred every two minutes worldwide in 2023.
Drugs Health Pharma

Maternal mortality rates may fail UN goal, global aid cuts the main culprit 

HQ Team April 9, 2025: The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40%.

Read More
AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.
Drugs Health Pharma

AstraZeneca’s lung cancer drug combination gets EU approval 

HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

Read More
Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European Union, the companies announced.
Drugs Medical Pharma

EU green lights AstraZeneca, Daiichi’s treatment for breast cancer

HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European.

Read More
Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.
Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease 

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

Read More
The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.
Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.

Read More
Siemens AG will acquire US, Boston-based Dotmatics for $5.1 billion from Insight Partners to expand its digital life sciences software applications.
Drugs Health Pharma

Siemens AG to acquire US-based Dotmatics for $5.1 billion

HQ Team April 3, 2025: Siemens AG will acquire US, Boston-based Dotmatics for $5.1 billion from Insight Partners to expand its digital life.

Read More
Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine.
Drugs Health Pharma

Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine

HQ Team April 2, 2025: Denmark’s Bavarian Nordic A/S has got approval from the US Food and Drug Administration for its freeze-dried formulation.

Read More
Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according to a UN official.
Drugs Health Medical

Sudan heading for famine as fighting ravages Darfur, UN warns

HQ Team April 2, 2025: Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according.

Read More
Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from Biogen Inc., for an undisclosed amount.
Drugs Medical Pharma

Organon & Co. buys biosimilar from Biogen for an undisclosed sum

HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.

Read More
Three-hundred and twenty-nine people died after being infected with cholera in the West African nation of Angola as the disease spread to 16 of the country’s 21 provinces, according to the World Health Organization.
Climate Drugs Health

Cholera claims lives of 329 people in Angola, WHO says spread risk is ‘high’

HQ Team April 1, 2025: Three-hundred and twenty-nine people died after being infected with cholera in the West African nation of Angola as.

Read More